Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the company is launching the process to identify a successor for Dr. Mikael Dolsten, Pfizer’s Chief Scientific Officer and ... Read More

Pfizer Launches Process To Identify Chief Scientific Officer Successor

Pifzer begins replacement process for chief scientific officer and president of Pfizer Research and Development. Mikael Dolsten, the current chief scientific officer and president, is set to leave the ... Read More

Pfizer Chief Scientific Officer Mikael Dolsten Leaving

Pfizer on Tuesday said Mikael Dolsten, chief scientific officer and president, Pfizer Research & Development, is leaving after more than 15 years with the drugmaker. Pfizer said it is launching the ... Read More

Pfizer's chief scientist Mikael Dolsten to step down

Pfizer worldwide research and development president Mikael Dolsten leaves after appearing at a commons science committee hearing at Portcullis House in London (Reuters) -Pfizer said on Tuesday Chief ... Read More

Pfizer Announces New Chief Scientific Officer and President, Research & Development

NEW YORK, November 20, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., ... Read More